66 related articles for article (PubMed ID: 8853263)
1. How to treat Helicobacter pylori infection--should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint.
de Boer WA; Tytgat GN
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):709-16. PubMed ID: 8853263
[TBL] [Abstract][Full Text] [Related]
2. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
de Boer WA; Haeck PW; Otten MH; Mulder CJ
Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
[TBL] [Abstract][Full Text] [Related]
3. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
4. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?
Breuer T; Graham DY
Am J Gastroenterol; 1999 Mar; 94(3):725-9. PubMed ID: 10086658
[TBL] [Abstract][Full Text] [Related]
5. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
7. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
[TBL] [Abstract][Full Text] [Related]
8. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
Hunt RH
Am J Gastroenterol; 1997 Apr; 92(4 Suppl):36S-40S; discussion 40S-43S. PubMed ID: 9127625
[TBL] [Abstract][Full Text] [Related]
9. Pylera for the eradication of Helicobacter pylori infection.
Saleem A; Qasim A; O'Connor HJ; O'Morain CA
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
[TBL] [Abstract][Full Text] [Related]
10. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
11. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
12. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
13. Attitude facing a patient suffering from Helicobacter pylori infection resistant to a triple therapy.
Gisbert JP; Pajares JM
Rev Esp Enferm Dig; 2003 Mar; 95(3):220-8, 210-19. PubMed ID: 12760711
[TBL] [Abstract][Full Text] [Related]
14. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].
Antelo P; Almuzara M; Avagnina A; Topor J; Barberis C; Barcia T; Araujo G; Vay C; Famiglietti A
Medicina (B Aires); 2001; 61(5 Pt 1):545-51. PubMed ID: 11721321
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of clarithromycin in eradicating Helicobacter pylori.
Satoh K; Kimura K; Takimoto T; Kihira K; Taniguchi Y; Saifuku K
J Gastroenterol; 1996 Nov; 31 Suppl 9():53-5. PubMed ID: 8959520
[TBL] [Abstract][Full Text] [Related]
17. Pooled analysis of anti-Helicobacter pylori treatment regimens.
Unge P; Berstad A
Scand J Gastroenterol Suppl; 1996; 220():27-40. PubMed ID: 8898433
[TBL] [Abstract][Full Text] [Related]
18. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
Leodolter A; Peitz U; Malfertheiner P
Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
[TBL] [Abstract][Full Text] [Related]
19. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
20. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.
Lerang F; Moum B; Ragnhildstveit E; Sandvei PK; Tolås P; Whist JE; Henriksen M; Haug JB; Berge T
Am J Gastroenterol; 1998 Feb; 93(2):212-6. PubMed ID: 9468244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
